← United States · Coverage record
US · SEC FORM 4
KORU Medical Systems, Inc.
KRMD · Nasdaq · CIK 0000704440 · Healthcare · Medical Instruments & Supplies
INSIDER SIGNAL
5 buyers · 9 purchase transaction lines · $215.3K gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Role scores low · most senior buyer: President-Chief Commercial Off (CEO, chair and 10% owners score lowest)
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Chief Technology Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 74.4
- 74.3
- 74.1
- 74.0
- 73.8
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -6.0%
- 3M
- -30.0%
- 6M
- -29.7%
- 12M
- -29.4%
Volatility & liquidity
- Volatility
- 58.4%
- Beta
- —
- Avg daily value
- USD 707,755
Valuation
- Market cap
- USD 136.7M
- P/E
- —
Fundamentals
- Profit margin
- -6.4%
- ROE
- -15.5%
- Industry
- Medical Instruments & Supplies
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-05 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 907,388
- Previous report
- 984,588
- Avg daily volume
- 356,634
- Days to cover
- 2.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | KALBERMATTEN ADAM R | Purchase (P) | Common Stock | 32,000 | USD 3.16 | USD 101,120 | SEC filing ↗ |
| 2026-06-11 | KALBERMATTEN ADAM R | Purchase (P) | Common Stock | 5,000 | USD 3.96 | USD 19,800 | SEC filing ↗ |
| 2026-06-11 | KALBERMATTEN ADAM R | Purchase (P) | Common Stick | 7,500 | USD 3.93 | USD 29,475 | SEC filing ↗ |
| 2026-05-18 | Schiller Eric | Purchase (P) | Common Stock | 5,000 | USD 3.91 | USD 19,550 | SEC filing ↗ |
| 2026-05-15 | Tharby Linda M | Purchase (P) | Common Stock | 1,191 | USD 3.92 | USD 4,669 | SEC filing ↗ |
| 2026-05-15 | Tharby Linda M | Purchase (P) | Common Stock | 1,191 | USD 1,191.00 | USD 1,418,481 | SEC filing ↗ |
| 2026-05-14 | Pazdan Christopher | Purchase (P) | Common Stock | 5,000 | USD 3.88 | USD 19,400 | SEC filing ↗ |
| 2026-05-14 | Adams Thomas Edward | Purchase (P) | Common Stock | 5,500 | USD 3.86 | USD 21,248 | SEC filing ↗ |
| 2023-12-13 | Manko Joseph M. Jr. | Purchase (P) | Common Stock | 145,833 | USD 2.40 | USD 349,999 | SEC filing ↗ |
| 2023-08-21 | Horton Capital Management, LLC; Horton Capital Partners Fund, L.P.; Horton Capital Partners, LLC; Horton Freedom, L.P.; Manko Joseph M. Jr. | Purchase (P) | Common Stock | 10,000 | USD 2.65 | USD 26,500 | SEC filing ↗ |
| 2023-08-18 | Tharby Linda M | Purchase (P) | Common Stock | 5,272 | USD 2.53 | USD 13,338 | SEC filing ↗ |
| 2023-08-18 | Horton Capital Management, LLC; Horton Capital Partners Fund, L.P.; Horton Capital Partners, LLC; Horton Freedom, L.P.; Manko Joseph M. Jr. | Purchase (P) | Common Stock | 10,000 | USD 2.54 | USD 25,400 | SEC filing ↗ |
| 2023-08-16 | CASCELLA ROBERT | Purchase (P) | Common Stock | 19,000 | USD 2.61 | USD 49,590 | SEC filing ↗ |
| 2022-05-13 | Tharby Linda M | Purchase (P) | Common Stock | 9,897 | USD 2.20 | USD 21,773 | SEC filing ↗ |
| 2022-05-13 | Horton Capital Management, LLC; Horton Capital Partners Fund, L.P.; Horton Capital Partners, LLC; Horton Freedom, L.P.; Manko Joseph M. Jr. | Purchase (P) | Common Stock | 20,000 | USD 2.15 | USD 43,000 | SEC filing ↗ |
Form 4 evidence
52 transaction lines in the latest 365-day window; 292 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | WHOLIHAN EDWARD | Award / grant (A) | Common Stock | 5,119 | USD 2.93 | USD 14,999 | SEC filing ↗ |
| 2026-10-01 | Matin Shahriar | Award / grant (A) | Common Stock | 5,119 | USD 2.93 | USD 14,999 | SEC filing ↗ |
| 2026-10-01 | French Donna | Award / grant (A) | Common Stock | 5,119 | USD 2.93 | USD 14,999 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | WHOLIHAN EDWARD | Award / grant (A) | Common Stock | 5,119 | USD 2.93 | USD 14,999 | SEC filing ↗ |
| 2026-10-01 | Matin Shahriar | Award / grant (A) | Common Stock | 5,119 | USD 2.93 | USD 14,999 | SEC filing ↗ |
| 2026-10-01 | French Donna | Award / grant (A) | Common Stock | 5,119 | USD 2.93 | USD 14,999 | SEC filing ↗ |
| 2026-10-01 | FLETCHER R JOHN | Award / grant (A) | Common Stock | 7,679 | USD 2.93 | USD 22,499 | SEC filing ↗ |
| 2026-10-01 | CASCELLA ROBERT | Award / grant (A) | Common Stock | 5,119 | USD 2.93 | USD 14,999 | SEC filing ↗ |
| 2026-09-30 | Horton Capital Management, LLC; Horton Capital Partners Fund, L.P.; Horton Capital Partners, LLC; Manko Joseph M. Jr. | Award / grant (A) | Common Stock | 5,119 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-08 | KALBERMATTEN ADAM R | Purchase (P) | Common Stock | 32,000 | USD 3.16 | USD 101,120 | SEC filing ↗ |
| 2026-07-28 | KALBERMATTEN ADAM R | Option exercise / conversion (M) | Common Stock | 75,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-28 | KALBERMATTEN ADAM R | Tax withholding (F) | Common Stock | 25,483 | USD 4.26 | USD 108,558 | SEC filing ↗ |
| 2026-07-01 | WHOLIHAN EDWARD | Award / grant (A) | Common Stock | 3,571 | USD 4.20 | USD 14,998 | SEC filing ↗ |
| 2026-07-01 | Matin Shahriar | Award / grant (A) | Common Stock | 3,571 | USD 4.20 | USD 14,998 | SEC filing ↗ |
| 2026-07-01 | French Donna | Award / grant (A) | Common Stock | 3,571 | USD 4.20 | USD 14,998 | SEC filing ↗ |
| 2026-07-01 | FLETCHER R JOHN | Award / grant (A) | Common Stock | 5,357 | USD 4.20 | USD 22,499 | SEC filing ↗ |
| 2026-07-01 | CASCELLA ROBERT | Award / grant (A) | Common Stock | 3,571 | USD 4.20 | USD 14,998 | SEC filing ↗ |
| 2026-06-30 | Horton Capital Management, LLC; Horton Capital Partners Fund, L.P.; Horton Capital Partners, LLC; Manko Joseph M. Jr. | Award / grant (A) | Common Stock | 3,571 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | KALBERMATTEN ADAM R | Purchase (P) | Common Stock | 5,000 | USD 3.96 | USD 19,800 | SEC filing ↗ |
| 2026-06-11 | KALBERMATTEN ADAM R | Purchase (P) | Common Stick | 7,500 | USD 3.93 | USD 29,475 | SEC filing ↗ |
| 2026-05-18 | Schiller Eric | Purchase (P) | Common Stock | 5,000 | USD 3.91 | USD 19,550 | SEC filing ↗ |
| 2026-05-15 | Tharby Linda M | Purchase (P) | Common Stock | 1,191 | USD 3.92 | USD 4,669 | SEC filing ↗ |
| 2026-05-15 | Tharby Linda M | Purchase (P) | Common Stock | 1,191 | USD 1,191.00 | USD 1,418,481 | SEC filing ↗ |
| 2026-05-14 | Tharby Linda M | Option exercise / conversion (M) | Common Stock | 13,977 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Tharby Linda M | Tax withholding (F) | Common Stock | 7,326 | USD 3.94 | USD 28,864 | SEC filing ↗ |
| 2026-05-14 | Pazdan Christopher | Purchase (P) | Common Stock | 5,000 | USD 3.88 | USD 19,400 | SEC filing ↗ |
| 2026-05-14 | Pazdan Christopher | Option exercise / conversion (M) | Common Stock | 5,327 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Pazdan Christopher | Tax withholding (F) | Common Stock | 1,470 | USD 3.94 | USD 5,792 | SEC filing ↗ |
| 2026-05-14 | Adams Thomas Edward | Purchase (P) | Common Stock | 5,500 | USD 3.86 | USD 21,248 | SEC filing ↗ |
| 2026-05-14 | Adams Thomas Edward | Option exercise / conversion (M) | Common Stock | 8,193 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Adams Thomas Edward | Tax withholding (F) | Common Stock | 2,900 | USD 3.94 | USD 11,426 | SEC filing ↗ |
| 2026-04-01 | WHOLIHAN EDWARD | Award / grant (A) | Common Stock | 3,472 | USD 4.32 | USD 14,999 | SEC filing ↗ |
| 2026-04-01 | Matin Shahriar | Award / grant (A) | Common Stock | 3,472 | USD 4.32 | USD 14,999 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | KRMD |
| CIK | 0000704440 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 292 transaction lines from 2020-01-06 to 2026-10-01 35 P purchase lines · 2 S sale lines · 255 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.